Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Poland

 

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 
July 3, 2019

LUX MED buys rival

Poland's largest private healthcare provider LUX MED has acquired a Warsaw-based competitor comprising two hospitals and a diagnostic centre.
July 1, 2019

DocPlanner flying towards Unicorn status

DocPlanner, the online booking and rating platform rival to Doctolib, has just closed a Series E funding round for €80m, but the company says it has "some way to go" to unicorn status. 
May 15, 2019

Ophthalmology: A birds eye view of a fragmented market

Ophthalmology may be a fragmented market, but international chains like Aier and Optegra are emerging. Can national operators build real competitive advantage in largely unconsolidated markets? And if so, how? HBI 2019 drew together CxOs from three large players as former ophthalmologist turned Mansfield Advisor Victor Chua chaired a session to find out more.
May 7, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us